SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-008092
Filing Date
2023-05-04
Accepted
2023-05-04 16:05:54
Documents
83
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q irwd-20230331x10q.htm   iXBRL 10-Q 1324263
2 EX-31.1 irwd-20230331xex31d1.htm EX-31.1 16575
3 EX-31.2 irwd-20230331xex31d2.htm EX-31.2 16634
4 EX-32.1 irwd-20230331xex32d1.htm EX-32.1 7973
5 EX-32.2 irwd-20230331xex32d2.htm EX-32.2 7937
  Complete submission text file 0001558370-23-008092.txt   6908935

Data Files

Seq Description Document Type Size
6 EX-101.SCH irwd-20230331.xsd EX-101.SCH 58284
7 EX-101.CAL irwd-20230331_cal.xml EX-101.CAL 61152
8 EX-101.DEF irwd-20230331_def.xml EX-101.DEF 263130
9 EX-101.LAB irwd-20230331_lab.xml EX-101.LAB 459996
10 EX-101.PRE irwd-20230331_pre.xml EX-101.PRE 428089
77 EXTRACTED XBRL INSTANCE DOCUMENT irwd-20230331x10q_htm.xml XML 1156176
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 23888619
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences